✦ LIBER ✦

Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial

✍ Scribed by Sean R.G. Duffy; Lydia Taylor

Book ID: 113427994
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 143 KB
Volume: 191
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2004.06.095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ATAC (Arimidex, Tamoxifen, alone or

The ATAC (Arimidex, Tamoxifen, alone or in combination) trial in post-menopausal patients with operable breast cancer

✍ J. Tobias 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 196 KB

The ATAC (Arimidex™, Tamoxifen, Alone or

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment

✍ Mike Baum 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Fewer endometrial abnormalities with ana

Fewer endometrial abnormalities with anastrozole than tamoxifen: Endometrial subprotocol results from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) early breast cancer trial in postmenopausal patients

✍ Sean Duffy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB

3–38 Quality of Life of Postmenopausal W

3–38 Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

✍ Vassilopoulou-Sellin, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

The ATAC (Arimidex™, Tamoxifen, Alone or

The ATAC (Arimidex™, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) patients (pts): Factors influencing the success of PT recruitment

✍ M. Baum 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d